Cognitive Behavior Therapy for Small Cell Lung Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Ohio State University Comprehensive Cancer Center, Columbus, OHSmall Cell Lung Cancer+1 MoreCognitive Behavior Therapy - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a form of cognitive-behavioral therapy can help reduce the intensity and frequency of dyspnea in patients with lung cancer.

Eligible Conditions
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Vancomycin
1
Nivolumab + Platinum Doublet Chemotherapy + SBRT (8gy x 3)
1
45 Gray (Gy) regimen

Study Objectives

5 Primary · 3 Secondary · Reporting Duration: Up to 1 month post-treatment

Month 1
Change in acceptability of Take a Breath (TAB)
Change in dyspnea severity using the American Thoracic Society Dyspnea Questionnaire
Change in shortness of breath
Change in tolerability of TAB
Month 1
Catastrophic thoughts related to dyspnea
Feasibility of TAB
Mood disturbance
Physical activity using International Physical Activity Questionnaire (IPAQ)

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Vancomycin
2
Nivolumab + Platinum Doublet Chemotherapy + SBRT (8gy x 3)
1
45 Gray (Gy) regimen

Trial Design

2 Treatment Groups

Arm II (usual care)
1 of 2
Arm I (TAB)
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Cognitive Behavior Therapy · No Placebo Group · N/A

Arm I (TAB)Experimental Group · 2 Interventions: Cognitive Behavior Therapy, Questionnaire Administration · Intervention Types: Behavioral, Other
Arm II (usual care)ActiveComparator Group · 2 Interventions: Questionnaire Administration, Best Practice · Intervention Types: Other, Other
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavior Therapy
2010
Completed Phase 3
~2360

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 month post-treatment

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
290 Previous Clinical Trials
286,099 Total Patients Enrolled
Barbara Andersen, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
3 Previous Clinical Trials
110 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been experiencing difficulty in breathing in the past 3 weeks, as measured by the American Thoracic Society Dyspnea Questionnaire score of 1 or higher.
References

Frequently Asked Questions

How many participants is the research team recruiting for this experiment?

"Affirmative. Clinicaltrials.gov has information indicating that this medical test is actively seeking volunteers, with the initial posting on July 1st 2020 and latest update being on March 22nd 2022. Currently, 40 people are required to be recruited from a single trial site." - Anonymous Online Contributor

Unverified Answer

Are recruiting efforts currently underway for this clinical experiment?

"Affirmative. According to the information located on clinicaltrials.gov, this research is actively recruiting participants as of March 22nd 2022 with a study initiation date of July 1st 2020. 40 volunteers are needed at one medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top